Alligator Bioscience
4,683
SEK
-5,96 %
Mindre end 1K følgere
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-5,96%
-40,72%
-90,82%
-77,76%
-93,51%
-93,98%
-95,29%
-98,56%
-99,73%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Læs mereMarkedsværdi
79,17 mio. SEK
Aktieomsætning
912,39 t SEK
Omsætning
57,77 mio.
EBIT %
-396,64 %
P/E
-
Udbytteafkast, %
-
Finanskalender
5.7
2025
Generalforsamling '25
10.7
2025
Delårsrapport Q2'25
23.10
2025
Delårsrapport Q3'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Alligator Bioscience AB reports financial results for Q1 2025 and provides a business update
Alligator Bioscience announces initiation of HLX22 Phase 2 trial in breast cancer by Shanghai Henlius Biotech, Inc.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools